Respiratory allergic diseases affect over 500 million people globally and pose a substantial
burden in terms of morbidity, mortality, and healthcare costs. Restrictive factors such as …

Patients' collaboration with healthcare providers, along with their individual dedication to
follow medical recommendations, is a crucial component of effective therapy in chronic …

Objective Millions of people in the UK have asthma, yet 70% do not access basic care,
leading to the largest number of asthma-related deaths in Europe. Chatbots may extend the …

Background The use of mobile health (mHealth) in asthma and chronic obstructive
pulmonary disease (COPD) is growing, and as the population ages, a greater number of …

Introduction Asthma is one of the most common chronic respiratory diseases globally.
Despite national and international asthma care guidelines, gaps persist in primary care …

Objectives We aimed to assess the acceptability of Mobile Direct Observed Therapy (MDOT)
amongst the parents/caregivers of children with asthma. Methods This open-label pilot …

This chapter provides a brief background of orally inhaled therapy and its potential benefits
compared to oral gastrointestinal delivery, then comprehensively reviews the four groups of …

Abstract In the Health 4.0 era, technological advances continue to bring major changes to
the health care industry. Artificial intelligence (AI)-based Mobile Health (mHealth) solutions …